Mesenchymal stromal cell (MSC) transplantation in septic shock. - MSC in septic shock

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites30 target enrollmentTBD

Conditionsseptisch shock septic shock and severe blood poisoning 10027665 10002252

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: septisch shock
Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment: 30
Status: Withdrawn
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Erasmus MC, Universitair Medisch Centrum Rotterdam

Eligibility Criteria

Inclusion Criteria

•Patients between 18 and 75 years, fulfilling the criteria for pneumonia septic shock. ;(see chapter 4\.2 and Appendix B of the research protocol)

Exclusion Criteria

•Moribund and where death is imminent, pregnancy, inflammatory diseases from any other origin then sepsis, chronic pulmonary or kidney disorders, active malignancies, single organ or other stem cell transplantations and participation in other clinical intervention studies. ;(see section 4\.3 of the research protocol)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting

Phase 1

Clinical study on mesenchymal Cell Therapy for SARS-CoV-2 PneumoniaSARS-CoV-2 pneumoniaMedDRA version: 22.1Level: LLTClassification code 10061229Term: Lung infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]

EUCTR2020-001577-70-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA60

Recruiting

Phase 2

Cotransplantation of mesenchymal stem cells with nonmyeloablative haploidentical peripheral blood stem cells without T cells deleted for high-risk acute leukemia: to reduce the severity of graft versus host disease and relapseHigh-risk acute leukemia patientsCancer - Leukaemia - Acute leukaemia

ACTRN12608000129381Huisheng Ai40

Not yet recruiting

Phase 1

Transplantation of stem cells for the treatment of type 1 diabetes.Type 1 diabetes mellitus (T1DM).Type 1 diabetes mellitus

IRCT20210925052566N1Endocrinology and Metabolism Research Institute30

Recruiting

Phase 1

Cell therapy with use of mesenchymal stem cells in infertile women with Thin Endometrium

IRCT20230222057500N1Tehran University of Medical Sciences10

Completed

Not Applicable

Clinical trial of mesenchymal stem cell transplantation for severe heart failureSevere chronic heart failure

JPRN-UMIN000000656ational Cardiovascular Center20